Adverse outcomes in patients with heart failure admitted for COVID-19 in association with renin-angiotensin-aldosterone system inhibitors

Pérez Belmonte, Luis M.Sanz-Cánovas, JaimeSalinas Botran, AlejandroGarcía Klepzig, José LuisMéndez Bailón, ManuelGómez Huelgas, Ricardo2025-10-142025-10-142021-10-22Pérez‑Belmonte LM, Sanz‑Cánovas J, Salinas A, et al. Ad‑ verse outcomes in patients with heart failure admitted for COVID‑19 in asso‑ ciation with the use of renin‑angiotensin‑aldosterone system inhibitors. Pol Arch Intern Med. 2022; 132: 16126. doi:10.20452/pamw.161261897-948310.20452/pamw.16126https://hdl.handle.net/20.500.14352/124905engAttribution-NonCommercial-ShareAlike 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-sa/4.0/Adverse outcomes in patients with heart failure admitted for COVID-19 in association with renin-angiotensin-aldosterone system inhibitorsjournal articlehttps://doi.org/10.20452/PAMW.1612634674519open access616.1/.9Medicina interna3205 Medicina Interna